Welcome : Guest

GLUCOSE MONITORING DEVICES - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Glucose Monitoring Devices in US$ by the following Product Segments: Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, & Lancets), and Continuous Glucose Monitoring (CGM). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 77 companies including many key and niche players such as -

Abbott Diabetes Care, Inc.
ACON Laboratories, Inc.
AgaMatrix, Inc.
Alive Technologies Pty. Ltd.
Apex Biotechnology Corp.
ARKRAY, Inc.

Click here to request a full list of companies covered in the report...

Code: MCP-3420
Price: $4950
Companies: 77
Pages: 417
Date: October 2017
Market Data Tables: 155
  Status: * New Report



TABLE OF CONTENTS


  GLUCOSE MONITORING DEVICES (Complete Report) Pages : 417   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Glucose Monitoring Devices: Enabling Easier and Efficient Monitoring of the Global
  Diabetes Epidemic.....II-1
2$200
   Growth Drivers in a Nutshell.....II-31$100
   Glucose Monitoring Undergoes Notable Transformation over the Years: An
  Evolutionary Scan.....II-4
Evolution of Diabetes Testing over the Years with Key Features in Each Period.....II-4
2$200
   Diabetes Incidence Reaching Epidemic Proportions Worldwide: Foundation for Market
  Growth.....II-6
2$200
   Table 1: Diabetes Prevalence Worldwide by Region: Number of Adults (20-79 Years) with Diabetes in 2015 and 2040 (includes corresponding Graph/Chart).....II-81$350
   Table 2: Global Prevalence (%) of Diabetes in Adults (20-79) by Region: 2015 & 2040 (includes corresponding Graph/Chart).....II-9

Table 3: Global Prevalence of Diabetes by Gender (2015 & 2040): Number of Adults Diagnosed with Diabetes (in Million) for Men and Women (includes corresponding Graph/Chart).....II-9
1$350
   Table 4: Worldwide Diabetes Prevalence (%) in Adults by Age Group and Gender: 2015 (includes corresponding Graph/Chart).....II-10

Table 5: Number of Adults with Diagnosed Diabetes in Urban and Rural Areas (2015 & 2040) (In Million) (includes corresponding Graph/Chart).....II-10
1$350
   Table 6: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2015 & 2040 (includes corresponding Graph/Chart).....II-111$350
   Diabetes: One of the Leading Causes of Death Globally.....II-12
Table 7: Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region (includes corresponding Graph/Chart).....II-12
1$350
   Diabetes Incidence and Prevalence by Region/Country.....II-13
North America.....II-13
United States.....II-13
Canada.....II-13
Mexico.....II-13
Europe.....II-13
Asia-Pacific.....II-13
Southeast Asian Region.....II-13
1$100
   Western Pacific Region.....II-14
South & Central America.....II-14
1$100
   Africa.....II-15
Global Market Outlook.....II-15
2$200
   Developed Countries are Dominant Markets, while Developing Countries Spearhead Market
  Growth.....II-17
China: A High Potential Market for Glucose Monitoring Devices.....II-17
1$100
   Rising Diabetic Populace Spurs Growth in the Indian Market.....II-18 1$100
   Table 8: Global Glucose Monitoring Devices Market - Geographic Regions Ranked by CAGR (Value) for 2016-2024: China, India, Russia, UK, Germany, Japan, France, Canada, Italy, Spain, and USA (includes corresponding Graph/Chart).....II-191$350
   The ‘Big Four’ Dominate the Global Self Glucose Monitoring (SGM) Market.....II-20 1$100
   Table 9: Leading Players in the Global Blood Glucose Monitoring Devices Market (2017E): Percentage Market Share Breakdown for Abbott, Ascensia/ Panasonic, LifeScan/J&J, Roche, and Others (includes corresponding Graph/Chart).....II-21
Major Pharma Players Dominate Blood Glucose Monitoring Market.....II-21
Innovations in BGM Devices Spearheaded by Startups.....II-21
1$350
   Competition with Local Pharma Companies Intensifies in Regional Markets.....II-22
Quality Products at Low Prices: Mantra for Success in the Marketplace.....II-22
After PDAs, SMBG Makers Turn to Mobile Devices to Woo Users on the Move.....II-22
1$100
   Dexcom and Medtronic Dominates the Global CGM Devices Market.....II-23 1$100
   Table 10: Leading Continuous Glucose Monitoring (CGM) Companies Worldwide (2017E): Percentage Breakdown of Value Sales for Abbott, Dexcom, Medtronic, and Others (includes corresponding Graph/Chart).....II-241$350
   Growing Popularity of Smart, Compact, Digital, Ergonomic, and Wireless Glucose
  Monitors Drive Healthy Market Growth.....II-25
1$100
   Select Disruptive Glucose Monitors Promising Reduced Pain, Lesser Data Load, and
  Zero Worries.....II-26
3$300
   Innovative Smart Glucometers for Sugar Monitoring.....II-29
iHealth Align.....II-29
1$100
   iHealth Smart.....II-30
iBGStar.....II-30
OneTouch Verio Sync.....II-30
Dario Smart Glucose Meter.....II-30
Dexcom G5 CGM System.....II-30
1$100
   Need for Real-Time Glucose Sensing and Monitoring Drive Strong Demand for
  Minimally-Invasive CGM Devices.....II-31
1$100
   Myriad Benefits of CGMs.....II-321$100
   CGM Market Gradually Breaks through Barriers to Adoption.....II-33
Table 11: Penetration Rate (%) of CGM Devices in Type 1 and Type 2 Diabetes Market in the United States: 2013 through 2020 (includes corresponding Graph/Chart).....II-33
1$350
   Intensive Care Units: A Highly Promising Market for CGMs.....II-34
Key Challenges Hampering Widespread Adoption of CGM Systems.....II-34
Despite Competition from CGM Systems, SGM Devices Continue to Dominate Sales.....II-34
2$200
   Blood Glucose Test Strips: The Largest Segment.....II-36
Cost: The Ultimate Factor Favoring Growth in Demand for Blood Glucose Monitoring
  Systems.....II-36
1$100
   Self-Monitoring/Household Blood Glucose: Sustaining Growth in Demand.....II-37
Table 12: Global Blood Glucose Monitoring Devices Market by Application Segment (2017E): Percentage Breakdown of Demand for Hospitals & Labs, Households, and Physician Clinics (includes corresponding Graph/Chart).....II-37
Key Trends in the Glucose Meter/Monitoring Systems.....II-37
1$350
   Smartphone Penetration Favors SMBG Market.....II-38 1$100
   Table 13: Global Smartphone Adoption Rate and Connections (2013-2020) (includes corresponding Graph/Chart).....II-39
Barriers to Adoption of New Technology in BGM Products.....II-39
2$350
   Accuracy Issues Plague Blood Glucose Meters Market.....II-411$100
   Advancements in Glucose Monitoring Devices Offers a New Ray of Hope.....II-42
Undiagnosed Diabetes: A Major Healthcare Challenge Offering Huge Untapped
  Potential.....II-42
1$100
   Table 14: Number of Undiagnosed Individuals (20-79 Years in Million) Living with Diabetes and Proportion (%) Worldwide by Region: 2015 (includes corresponding Graph/Chart).....II-431$350
   Undiagnosed Diabetics: More Prone to Cardiovascular Diseases.....II-44
Increased Vulnerability of Diabetics to Various Health Complications Drives the Need
  for Timely Glucose Monitoring.....II-44
1$100
   Heart Disease.....II-45
Stroke.....II-45
High Blood Pressure.....II-45
Blindness.....II-45
Kidney Disease.....II-45
Nerve Disease.....II-45
Amputations.....II-45
Dental Disease.....II-45
Pregnancy.....II-45
1$100
   Microvascular Complications (Small Blood Vessel Damage).....II-46
Retinopathy.....II-46
Diabetic Neuropathy.....II-46
Nephropathy.....II-46
Macrovascular Complications (Large Blood Vessel Damage).....II-46
Cardiac Problems.....II-46
Hypertension (High Blood Pressure).....II-46
Infections.....II-46
1$100
   Impotence.....II-47
Pregnancy Complications.....II-47
Other Complications Resulting from Diabetes.....II-47
Obesity.....II-47
Obsessive Compulsive Disorder.....II-47
Foot Ulcers.....II-47
1$100
   Dementia.....II-48
Hypoglycemia.....II-48
1$100
   Diabetic Ketoacidosis.....II-49
Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Lead to Cardiovascular
  Complications.....II-49
1$100
   Higher Risk of Diabetes in the Fast Expanding Aging Population Benefit Market
  Expansion.....II-50
1$100
   Demographic Statistics of the Global Aging Populace: Unfurling the Market
  Potential.....II-51
Table 15: Global Aging Population (in Thousands) by Age Group: 1975-2050 (includes corresponding Graph/Chart).....II-51
1$350
   Table 16: Global Population Statistics for the 65+ Age Group (2016) (includes corresponding Graph/Chart).....II-521$350
   Table 17: Life Expectancy for Select Countries in Number of Years: 2016 (includes corresponding Graph/Chart).....II-531$350
   Increasing Healthcare Expenditure Boosts Demand for SGM and CGM Devices.....II-54 1$100
   Table 18: Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart).....II-55

Table 19: Per Capita Healthcare Spending (in $) in Select Developed Countries for the Year 2016 (includes corresponding Graph/Chart).....II-55
1$350
   Expenditure on Diabetes Management.....II-56
Table 20: Global Prevalence of Diabetes and Expenditure on its Management by Region (2015 & 2040P): Number of People Diagnosed with Diabetes in the Age Group 20-79 Years (Billions) and Expenditure on Management of Diabetes and its Complications (in US$ Billions) (includes corresponding Graph/Chart).....II-56
1$350
   Table 21: Leading Countries by Health Expenditure on Diabetes (2015 & 2040) (in US$ Billion) (includes corresponding Graph/Chart).....II-571$350
   Table 22: Expenditure on Diabetes in Adult (20-79) as % of Total Healthcare Spending by Region (2015) (includes corresponding Graph/Chart).....II-581$350
   Table 23: Health Expenditure on Diabetes by Region: Average Diabetes-Related Spending per Person with Diabetes in US$ for 2015 (includes corresponding Graph/Chart).....II-591$350
   Table 24: Health Expenditure on Diabetes (2015): Average Diabetes-Related Spending per Person with Diabetes (US$) in Select Countries (includes corresponding Graph/Chart).....II-601$350
   Increasing Obesity Levels Underpins Market Growth.....II-61
Table 25: Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 (includes corresponding Graph/Chart).....II-61
1$350
   Table 26: Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart).....II-621$350
   K’Track: Discreet and Painless Glucose- Monitoring Wearable.....II-631$100
   The Sugar iQ App Provide Predictive Diabetes Care.....II-64
DIABNEXT® CLIPSULIN®: World’s First A.I Tool for Diabetes.....II-64
1$100
   e-mosquito CGM Device.....II-65
FreeStyle Libre Flash Glucose Monitoring System.....II-65
1$100
   MyDario Mobile Data Management Platform.....II-66
The New Handheld RL-BGM Device.....II-66
1$100
   TOUCH TG.....II-67
Pocket-Sized Gadgets.....II-67
Digital Contact Lenses.....II-67
1$100
   Gamification.....II-68
Leveraging Big Data.....II-68
Digital Tattoos.....II-68
OneTouch® Verio Flex® Monitoring System.....II-68
1$100
   Artificial Pancreas System (APS): The Next Big Thing in Glucose Monitoring.....II-691$100
   The First-of-its-Kind Artificial Pancreas by Medtronic.....II-701$100
   Non-invasive, Acetone Detecting Breathalyzer for Glucose Testing.....II-71
Nanotechnology-based Breathalyzer for Non-Invasive Glucose Monitoring.....II-71
1$100
   EMG 1000: Needle-free Device for Glucose Monitoring.....II-72
Glucase: Smartphone Case with Glucose Testing Kit.....II-72
Painless Diabetes Monitoring Using NFC Technology.....II-72
1$100
   GlucoSense: Laser Device for Non-invasive Monitoring of Glucose Levels.....II-731$100
   ClearPath DS-120: Enabling Early Detection of Diabetes & Prediabetes.....II-74
NoStrip™ Technology: Eliminating Need for Individual Test Strips.....II-74
Other Innovative and Advanced Glucose Monitoring Systems.....II-74
GlucoTrack®.....II-74
1$100
   A2I.....II-75
Omnipod Horizon.....II-75
V-Go.....II-75
sugarBEAT.....II-75
G5 Integrated Vibe Insulin Pump and CGM System.....II-75
1$100
   FreeStyle Libre and FreeStyle Libre Pro.....II-76
Contour Next One and Contour Next Link.....II-76
Bewell Connects.....II-76
Biosensor-based Monitor called Lumee.....II-76
1$100
   Touchscreen Receiver/Android App.....II-77
OneTouch Via.....II-77
MiniMed 670G/Enlite 3 with Hybrid Closed Loop.....II-77
Dexcom G5 Mobile CGM with Bluetooth.....II-77
Dario-Smart Meter from LabStyle.....II-77
Notable Early-stage Investigative Glucose Monitoring Devices.....II-77
2$200
   What is Diabetes?.....II-79
Types of Diabetes.....II-79
Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM).....II-79
1$100
   Type II Diabetes: Non-Insulin Dependent Diabetes Mellitus (NIDDM).....II-801$100
   NIDDM: Higher Risk of Cardiovascular Disease.....II-81
Gestational Diabetes.....II-81
Impaired Fasting Glycaemia (IFG) & Impaired Glucose Tolerance (IGT).....II-81
Glucose Monitoring Devices.....II-81
Self Glucose Monitoring (SGM) Devices.....II-81
1$100
   Blood Glucose Meters.....II-821$100
   Measurement Units.....II-83
Blood Glucose Strips.....II-83
Lancets.....II-83
1$100
   Continuous Glucose Monitoring (CGM) Systems.....II-84
Operation of a Continuous Glucose Monitor (CGM).....II-84
1$100
   ARKRAY Releases PocketChem VC PV-1350on Reducing Substances Meter.....II-85
ARKRAY Releases BG Sensor.....II-85
The U.S. Food and Drug Administration Approves Abbott’ Glucose Monitoring
  Device.....II-85
ARKRAY Releases Glycohemoglobin Analyzer ADAMS A1c HA-8190V.....II-85
Intel Releases New Software Application Platform, IntelHAP.....II-85
ARKRAY Releases GLUCOCARD W Blood Glucose Meter.....II-85
Abbott's FreeStyle Libre Pro System Receives FDA Approval.....II-85
1$100
   Roche Launches Accu-Chek Guide® System.....II-86
Ascensia Launches CONTOUR®NEXT LINK 2.4 Blood Glucose Monitoring System
  (BGMS).....II-86
ACON Laboratories Launches On Call® Pro Blood Glucose Meter.....II-86
LifeScan Introduces OneTouch Verio Flex™.....II-86
1$100
   AgaMatrix Inc. Enters into a $32 Million Senior Term Loan Facility with
  Prospect.....II-87
Fitbit Partners with Dexcom.....II-87
Abbott Enters into Collaboration with Bigfoot Biomedical.....II-87
Roche Acquires mySugr.....II-87
Abbott Obtains the Health Canada License for FreeStyle® Libre Flash Glucose Monitoring
  System.....II-87
Roche Signs a Partnership Agreement with Medtronic.....II-87
TGA Approves for Abbott’s FreeStyle® Libre System.....II-87
1$100
   Glooko and Diasend Enter into Merger.....II-88
BioTelemetry Acquires Telcare Medical Supply.....II-88
Mitsui to Acquire Shares in Panasonic Healthcare Holdings.....II-88
ARKRAY Collaborates with LG Life Sciences Ltd......II-88
Ascensia Diabetes Care Renews Global Alliance with Medtronic.....II-88
Senseonics Signs Distribution Agreement with Roche.....II-88
Dexcom G5® Mobile Continuous Glucose Monitoring System Now Available on the Apple
  Watch.....II-88
1$100
   Cellnovo Signs a Commercial Agreement with Roche.....II-89
Nemaura’ sugarBEAT® Receives Notification of CE Approval.....II-89
Tekcapital PLC Acquires the License for the Measurement of Glucose in Saliva.....II-89
Abbott Obtains CE Mark for the FreeStyle Libre System.....II-89
Nova Biomedical’s StatStrip Glucose Xpress 2 Receives FDA Clearance.....II-89
Sinocare Acquires Nipro Diagnostics Inc......II-89
LabStyle’s Dario System Receives FDA Clearance.....II-89
Panasonic Healthcare Acquires the Bayer Diabetes Care Business.....II-89
1$100
   Abbott Diabetes Care, Inc. (USA).....II-90
ACON Laboratories, Inc. (USA).....II-90
AgaMatrix, Inc. (USA).....II-90
1$100
   Alive Technologies Pty. Ltd. (Australia).....II-91
Apex Biotechnology Corp. (Taiwan).....II-91
1$100
   ARKRAY, Inc. (Japan).....II-92
Arkray USA, Inc. (USA).....II-92
Ascensia Diabetes Care Holdings AG (Switzerland).....II-92
1$100
   B. Braun Melsungen AG (Germany).....II-93
Beurer GmbH (Germany).....II-93
1$100
   BIONIME Corporation (Taiwan).....II-94
Dexcom, Inc. (USA).....II-94
Entra Health Systems LLC (USA).....II-94
1$100
   GlySens Incorporated (USA).....II-95
LifeScan, Inc. (USA).....II-95
Medtronic plc (Ireland).....II-95
1$100
   Medtronic MiniMed, Inc. (USA).....II-96
Nova Biomedical Corporation (USA).....II-96
1$100
   Omron Healthcare Co., Ltd. (Japan).....II-97
Roche Diagnostics (Switzerland).....II-97
1$100
   Sanofi S.A. (France).....II-98
Sanwa Kagaku Kenkyusho Co, Ltd. (Japan).....II-98
Senseonics Holdings, Inc. (USA).....II-98
1$100
   Taidoc Technology Corporation (Taiwan).....II-99
Terumo Corporation (Japan).....II-99
1$100
   Trividia Health, Inc. (USA).....II-100
Ypsomed Holding AG (Switzerland).....II-100
1$100
   Table 27: World Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-1011$350
   Table 28: World Historic Review for Glucose Monitoring Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-1021$350
   Table 29: World 14-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-1031$350
   Glucose Monitoring Devices by Product Group/Segment.....II-104
Table 30: World Recent Past, Current & Future Analysis for Self Glucose Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-104
1$350
   Table 31: World Historic Review for Self Glucose Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-1051$350
   Table 32: World 14-Year Perspective for Self Glucose Monitoring by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-1061$350
   Table 33: World Recent Past, Current & Future Analysis for Self Glucose Monitoring by Product Segment - Blood Glucose Strips, Blood Glucose Meters, and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-1071$350
   Table 34: World Historic Review for Self Glucose Monitoring by Product Segment - Blood Glucose Strips, Blood Glucose Meters, and Lancets Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-1081$350
   Table 35: World 14-Year Perspective for Self Glucose Monitoring by Product Segment - Percentage Breakdown of Revenue in Dollars for Blood Glucose Strips, Blood Glucose Meters, and Lancets Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-1091$350
   Table 36: World Recent Past, Current & Future Analysis for Blood Glucose Strips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-1101$350
   Table 37: World Historic Review for Blood Glucose Strips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-1111$350
   Table 38: World 14-Year Perspective for Blood Glucose Strips by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-1121$350
   Table 39: World Recent Past, Current & Future Analysis for Blood Glucose Meters by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-1131$350
   Table 40: World Historic Review for Blood Glucose Meters by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-1141$350
   Table 41: World 14-Year Perspective for Blood Glucose Meters by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-1151$350
   Table 42: World Recent Past, Current & Future Analysis for Lancets by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-1161$350
   Table 43: World Historic Review for Lancets by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-1171$350
   Table 44: World 14-Year Perspective for Lancets by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-1181$350
   Table 45: World Recent Past, Current & Future Analysis for Continuous Glucose Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-1191$350
   Table 46: World Historic Review for Continuous Glucose Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-1201$350
   Table 47: World 14-Year Perspective for Continuous Glucose Monitoring by Geographic Region - Percentage Breakdown of Revenue in Dollars for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-1211$350
   A. Market Analysis.....III-1
The US: The Largest Glucose Monitoring Devices Market Worldwide.....III-1
1$75
   Table 48: Diabetes and Population Statistics in North America and Caribbean Region (2015 & 2040) (includes corresponding Graph/Chart).....III-21$200
   Table 49: Diabetes Statistics in the US (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s).....III-3
Growth Drivers in a Nutshell.....III-3
1$200
   Aging Population: A Weighty Growth Factor.....III-4
Table 50: Diabetes Prevalence in the US (2015E): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart).....III-4

Table 51: Diabetes Prevalence in the US (2015E): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart).....III-4
1$200
   Table 52: Aging Population in the US (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-5

Table 53: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart).....III-5
1$200
   Economic Burden of Diabetes.....III-6
Table 54: Health Expenditure (in US$ Billion) on Diabetes in the US: 2015 & 2040 (includes corresponding Graph/Chart).....III-6
Healthcare Reform Legislation: Impact on Glucose Monitoring Devices.....III-6
1$200
   Wearable and Non-Invasive Glucose Monitoring Devices Favored.....III-71$75
   Innovations in BGM Devices: The Key Challenges Faced by Developers.....III-81$75
   Emerging "Grey Market" for Testing Strips.....III-9
Clinical Study Raises Doubts over Utility of Self Blood Glucose Monitoring.....III-9
1$75
   Regulatory Landscape.....III-10
FDA Guidance for Blood Glucose Meters.....III-10
FDA’s Final Recommendations for New Blood Glucose Monitoring Devices.....III-10
1$75
   FDA’s Proposal to Improve Blood Glucose Meter Accuracy in Critical Care Units
  Gathers Criticism.....III-11
Regulations on Lancet Needles to be made More Stringent by FDA.....III-11
1$75
   TGC Protocols: A Key Driver for Point of Care BGM Market.....III-12
Competitive Landscape.....III-12
CGM Devices Marketplace: Highly Consolidated.....III-12
Table 55: Leading Companies in the US CGM Market (2016 & 2020P): Percentage Share Breakdown of Revenue for Abbott, DexCom, Medtronic, and Others (includes corresponding Graph/Chart).....III-12
1$200
   Companies Focus on Research for Better Glucose Monitoring.....III-13
Drugstores Benefit from the Diabetic Care Category.....III-13
Integrated Products: An Upcoming Trend.....III-13
1$75
   Product Launches.....III-141$75
   Strategic Corporate Developments.....III-151$75
   Select Key Players.....III-166$450
   B. Market Analytics.....III-22
Table 56: US Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-22
1$200
   Table 57: US Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-231$200
   Table 58: US 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-241$200
   A. Market Analysis.....III-25
Diabetes Statistics and Aging Population in Canada: Opportunity Indicators for
  Glucose Monitoring Devices.....III-25
Table 59: Diabetes Statistics in Canada (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s).....III-25

Table 60: Adult Diabetes in Canada (2017E): Percentage Share Breakdown of Diabetic Population by Gender (includes corresponding Graph/Chart).....III-25
1$200
   Table 61: Adult Diabetes in Canada (2017E): Percentage Share Breakdown of Diabetic Population by Age Group (includes corresponding Graph/Chart).....III-26

Table 62: Aging Population in Canada (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-26
Product Launch.....III-26
1$200
   B. Market Analytics.....III-27
Table 63: Canadian Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-27
1$200
   Table 64: Canadian Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-281$200
   Table 65: Canadian 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-291$200
   A. Market Analysis.....III-30
Rapidly Growing Aging Population and their Vulnerability to Diabetes Sustains
  Market Demand.....III-30
1$75
   Table 66: Aging Population in Japan (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-31
Trends Influencing Glucose Monitoring Market Summarized.....III-31
Table 67: Diabetes Statistics in Japan (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-31
1$200
   Product Launch.....III-32
Strategic Corporate Development.....III-32
Select Key Players.....III-32
2$150
   B. Market Analytics.....III-34
Table 68: Japanese Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-34
1$200
   Table 69: Japanese Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-351$200
   Table 70: Japanese 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-361$200
   A. Market Analysis.....III-37
Healthy Growth Projected for the European Glucose Monitoring Devices
  Market.....III-37
1$75
   Diabetes Statistics in Europe.....III-38
Table 71: Diabetes and Population Statistics in Europe (2015 & 2040) (includes corresponding Graph/Chart).....III-38
1$200
   Table 72: Diabetes Statistics in Europe (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-391$200
   Reimbursement Scenario.....III-401$75
   B. Market Analytics.....III-41
Table 73: European Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-41
1$200
   Table 74: European Historic Review for Glucose Monitoring Devices by Geographic Region - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-421$200
   Table 75: European 14-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Revenue in Dollars for France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-431$200
   Table 76: European Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-441$200
   Table 77: European Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-451$200
   Table 78: European 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-461$200
   A. Market Analysis.....III-47
Diabetes & Aging Statistics: Opportunity Indicators for the French Market.....III-47
Table 79: Diabetes Statistics in France (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s) .....III-47

Table 80: Aging Population in France (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-47
1$200
   Strategic Corporate Development.....III-48
Sanofi S.A. - A Major France-Based Company.....III-48
1$75
   B. Market Analytics.....III-49
Table 81: French Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-49
1$200
   Table 82: French Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-501$200
   Table 83: French 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-511$200
   A. Market Analysis.....III-52
Diabetes & Aging Statistics: Opportunity Indicators for the German Market.....III-52
Table 84: Diabetes Statistics in Germany (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-52

Table 85: Aging Population in Germany (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-52
1$200
   Select Key Players.....III-531$75
   B. Market Analytics.....III-54
Table 86: German Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-54
1$200
   Table 87: German Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-551$200
   Table 88: German 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-561$200
   A. Market Analysis.....III-57
Diabetes & Aging Statistics: Opportunity Indicators for the Italian Market.....III-57
Table 89: Diabetes Statistics in Italy (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-57

Table 90: Aging Population in Italy (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-57
1$200
   B. Market Analytics.....III-58
Table 91: Italian Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-58
1$200
   Table 92: Italian Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-591$200
   Table 93: Italian 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-601$200
   A. Market Analysis.....III-61
The United Kingdom: One of the Leading Spenders on Diabetes Related
  Healthcare.....III-61
Table 94: Diabetes Statistics in United Kingdom (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-61

Table 95: Aging Population in the United Kingdom (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-61
1$200
   Rising Obesity Cases – Increased Risk of Diabetes.....III-62
Type 1 Diabetes in Children.....III-62
1$200
   Table 96: Number of Children with Type 1 Diabetes in Select Countries (2015) (includes corresponding Graph/Chart).....III-63
NHS England Launches Action for Diabetes Plan.....III-63
NHS Guidelines for Lancets, Testing Strips, and Meters for Blood Glucose
  Testing.....III-63
1$200
   Self-Monitoring Blood Glucose Meters Gain Popularity.....III-64
NICE Recommendations for Self-Monitoring Blood Glucose (SMBG).....III-64
1$75
   Strategic Corporate Development.....III-651$75
   B. Market Analytics.....III-66
Table 97: UK Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-66
1$200
   Table 98: UK Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-671$200
   Table 99: UK 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-681$200
   A. Market Analysis.....III-69
Spain: Diabetes & Aging Statistics.....III-69
Table 100: Diabetes Statistics in Spain (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-69

Table 101: Aging Population in Spain (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-69
1$200
   B. Market Analytics.....III-70
Table 102: Spanish Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-70
1$200
   Table 103: Spanish Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-711$200
   Table 104: Spanish 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-721$200
   A. Market Analysis.....III-73
Large Proportion of Undiagnosed Population Provides Market Growth
  Opportunities.....III-73
Diabetes & Aging Statistics.....III-73
Table 105: Diabetes Statistics in Russia (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s) .....III-73
1$200
   Table 106: Aging Population in Russia (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-741$200
   B. Market Analytics.....III-75
Table 107: Russian Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-75
1$200
   Table 108: Russian Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-761$200
   Table 109: Russian 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-771$200
   A. Market Analysis.....III-78
Product Launch.....III-78
Strategic Corporate Developments.....III-78
1$75
   Select Key Players.....III-792$150
   B. Market Analytics.....III-81
Table 110: Rest of Europe Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-81
1$200
   Table 111: Rest of Europe Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-821$200
   Table 112: Rest of Europe 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-831$200
   A. Market Analysis.....III-84
High Risk Population and Underpenetrated Nature of the Market Offers Huge Growth
  Opportunities.....III-84
1$75
   Table 113: Global Glucose Monitoring Devices Market - Geographic Regions Ranked by CAGR (Value) for 2016-2024: China, India, Russia, UK, Germany, Japan, France, Canada, Italy, Spain, and USA (includes corresponding Graph/Chart).....III-851$200
   Table 114: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart).....III-861$200
   Table 115: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-871$200
   Table 116: Diabetes and Population Statistics in South East Asia (2015 & 2040) (includes corresponding Graph/Chart).....III-881$200
   Table 117: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-89
Role of Healthcare Societies and Associations.....III-89
India.....III-89
1$200
   Bangladesh.....III-90
Western Pacific Declaration on Diabetes.....III-90
Public and Private Sector Diabetes Care.....III-90
Public Sector.....III-90
1$75
   Private Sector.....III-91
B. Market Analytics.....III-91
Table 118: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-91
1$200
   Table 119: Asia-Pacific Historic Review for Glucose Monitoring Devices by Geographic Region - China, India, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-921$200
   Table 120: Asia-Pacific 14-Year Perspective for Glucose Monitoring Devices by Geographic Region - Percentage Breakdown of Revenue in Dollars for China, India, and Rest of Asia-Pacific Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-931$200
   Table 121: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-941$200
   Table 122: Asia-Pacific Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-951$200
   Table 123: Asia-Pacific 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-961$200
   A. Market Analysis.....III-97
China: A Market with Huge Untapped Potential for Glucose Monitoring
  Devices.....III-97
1$75
   Table 124: Leading Companies in the Chinese Glucose Meter Market (2017E): Percentage Share Breakdown of Revenue for Abbott, Ascensia, J&J, Omron, Roche, Sinocare & Yuyue (includes corresponding Graph/Chart).....III-98
Reimbursement of Glucose Monitoring Devices in China (2015): Glucose Meters and
  Test Strips’ Reimbursement Status and Percentage.....III-98
Increasing Diabetes Incidence Remains an Important Growth Driver.....III-98
1$200
   Table 125: Diabetes Statistics in China (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s) .....III-991$200
   Key Opportunity Indicator: Aging Population.....III-100
Table 126: Aging Population in China (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-100
Strategic Corporate Development.....III-100
1$200
   B. Market Analytics.....III-101
Table 127: Chinese Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-101
1$200
   Table 128: Chinese Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1021$200
   Table 129: Chinese 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-1031$200
   A. Market Analysis.....III-104
Diabetic Epidemic in the Country Drives Strong Demand for Glucose Monitoring
  Devices.....III-104
1$75
   Table 130: Diabetes Statistics in India (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s).....III-105
Growth Stimulants & Challenges in a Nutshell.....III-105
Most Glucose Meters in Indian Market Feature Imported Technology.....III-105
1$200
   ICMR Develops New Indigenous, Low-Cost Diabetes Detection Technology.....III-1061$75
   Market Restraints.....III-1071$75
   B. Market Analytics.....III-108
Table 131: Indian Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-108
1$200
   Table 132: Indian Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1091$200
   Table 133: Indian 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-1101$200
   A. Market Analysis.....III-111
Surging Number of Aging Individuals and Diabetic Patients Drive Market
  Adoption.....III-111
1$75
   Table 134: Aging Population in Rest of Asia by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-112
Australia: A Growing Market for Glucose Monitoring Devices.....III-112
1$200
   Table 135: Diabetes Population in Australia (2015): Percentage Share Breakdown of Number of Diabetics by Age Group (includes corresponding Graph/Chart).....III-113

Table 136: Diabetes Statistics in Australia (2015) - Number of Adults with Diabetes (in 000s), Adults with Undiagnosed Diabetes (in ‘000s), National Diabetes Prevalence (%), Number of Diabetes-Related Deaths (in ‘000s), and No. of Children with Type 1 diabetes (in ‘000s) (includes corresponding Graph/Chart).....III-113
1$200
   Product Launch.....III-114
Strategic Corporate Development.....III-114
Select Key Players.....III-114
2$150
   B. Market Analytics.....III-116
Table 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-116
1$200
   Table 138: Rest of Asia-Pacific Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1171$200
   Table 139: Rest of Asia-Pacific 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-1181$200
   A. Market Analysis.....III-119
Diabetes in Latin America: Key Statistics.....III-119
1$75
   Table 140: Diabetes and Population Statistics in Central and South America (2015 & 2040) (includes corresponding Graph/Chart).....III-1201$200
   Table 141: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-1211$200
   Key Opportunity Indicator: Aging Population.....III-122
Table 142: Aging Population in Latin America and the Caribbean by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-122
1$200
   Table 143: Aging Population in Latin America by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-1231$200
   B. Market Analytics.....III-124
Table 144: Latin American Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-124
1$200
   Table 145: Latin American Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1251$200
   Table 146: Latin American 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-1261$200
   A. Market Analysis.....III-127
Diabetes Statistics in Africa and the Middle East.....III-127
Table 147: African Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart).....III-127
1$200
   Table 148: Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-1281$200
   Table 149: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart).....III-1291$200
   Table 150: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-1301$200
   Key Opportunity Indicator: Aging Population.....III-131
Table 151: Aging Population in the Middle East by Country (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-131
1$200
   Table 152: Aging Population in Africa by Region (2015 & 2030): 60 Years and Above Population (in Thousands) and Percentage of Population (includes corresponding Graph/Chart).....III-1321$200
   B. Market Analytics.....III-133
Table 153: Rest of World Recent Past, Current & Future Analysis for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-133
1$200
   Table 154: Rest of World Historic Review for Glucose Monitoring Devices by Product Segment - Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-1341$200
   Table 155: Rest of World 14-Year Perspective for Glucose Monitoring Devices by Product Segment - Percentage Breakdown of Revenue in Dollars for Self Glucose Monitoring (Blood Glucose Strips, Blood Glucose Meters, and Lancets), and Continuous Glucose Monitoring Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-1351$200
  
Total Companies Profiled: 77 (including Divisions/Subsidiaries - 89)

Region/Country Players

The United States 38 Canada 2 Japan 5 Europe 24 France 1 Germany 4 The United Kingdom 6 Italy 1 Rest of Europe 12 Asia-Pacific (Excluding Japan) 18 Middle East 1 Latin America 1
Click here to request a full table of contents and more details on this project.